Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/192
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)
Description:










Sub-classes under this class:

Class Number Class Name Patents
514/195 3-position substituent contains -cooc- group 167
514/194 6,6-di-substituted 57
514/197 6-position substituent contains carbocyclic ring 115
514/196 6-position substituent contains hetero ring 131
514/193 Spiro or additional polycyclo ring system 80


Patents under this class:
1 2 3 4 5 6

Patent Number Title Of Patent Date Issued
8685957 Tazobactam arginine compositions Apr. 1, 2014
8685453 Extended-release formulation for reducing the frequency of urination and method of use thereof Apr. 1, 2014
8461143 Stabilizing compositions for antibiotics and methods of use Jun. 11, 2013
8426373 Stable pharmaceutical composition comprising beta-lactam antibiotic and ion-chelating agent Apr. 23, 2013
8299052 Pharmaceutical compositions and methods for improved bacterial eradication Oct. 30, 2012
8273732 Compositions for combating beta-lactamase-medicated antibiotic resistance using beta-lactamase inhibitors useful for injection Sep. 25, 2012
8231871 Perorally administrable antimicrobial composition Jul. 31, 2012
8178087 Process of production of bacteriophage compositions and methods in phage therapy field May. 15, 2012
8158152 Lyophilization process and products obtained thereby Apr. 17, 2012
8133883 Compositions containing piperacillin and tazobactam useful for injection Mar. 13, 2012
8106040 Stabilizing compositions for antibiotics and methods of use Jan. 31, 2012
8093294 Metallo-.beta.-lactamase inhibitors Jan. 10, 2012
8030299 Palladium complexes inhibit N-myristoyltransferase activity in vitro and cancer growth in vivo Oct. 4, 2011
7915229 Compositions containing piperacillin and tazobactam useful for injection Mar. 29, 2011
7807151 Probiotic, lactic acid-producing bacteria and uses thereof Oct. 5, 2010
7776850 Methods and compositions for the treatment of asthma and related disorders Aug. 17, 2010
7723389 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity May. 25, 2010
7696211 Methods and pharmaceutical compositions for treating sepsis Apr. 13, 2010
7687488 2-substituted methyl penam derivatives Mar. 30, 2010
7687519 Biphenyl compounds useful as muscarinic receptor antagonists Mar. 30, 2010
7666860 Melt-formulated, multi-particulate oral dosage form Feb. 23, 2010
7595310 Glucuronate salt of a piperazine compound Sep. 29, 2009
7498312 Compositions containing piperacillin and tazobactam useful for injection Mar. 3, 2009
7307062 Method for treating a mental disorder Dec. 11, 2007
7241741 Methods and compositions for the treatment of asthma and related disorders Jul. 10, 2007
7101572 Taste masked aqueous liquid pharmaceutical composition Sep. 5, 2006
7094397 Methods and reagents for the treatment of multiple sclerosis Aug. 22, 2006
7094431 Method of healing skin wounds in mammals and a composition therefor Aug. 22, 2006
7067500 Betaines as adjuvants to susceptibility testing and antimicrobial therapy Jun. 27, 2006
6949519 Macrolide solvates Sep. 27, 2005
6900184 Compositions containing pipercillin and tazobactam useful for injection May. 31, 2005
6890526 Methods and reagents for the treatment of multiple sclerosis May. 10, 2005
6884784 Diagnosis and management of infection caused by chlamydia Apr. 26, 2005
6806256 Taste masked liquid pharmaceutical compositions Oct. 19, 2004
6756369 Diagnosis and management of infection caused by Chlamydia Jun. 29, 2004
6743440 Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals Jun. 1, 2004
6706290 Methods for eradication of nanobacteria Mar. 16, 2004
6689756 Treatment of neurological disease Feb. 10, 2004
6664239 Diagnosis and management of infection caused by Chlamydia Dec. 16, 2003
6630135 Use of sustained release antibiotic compositions in ophthalmic surgical procedures Oct. 7, 2003
6627625 Treatment of behavioral disorders with .beta.-lactam compounds Sep. 30, 2003
6610652 Microdose therapy Aug. 26, 2003
6579854 Diagnosis and management of infection caused by chlamydia Jun. 17, 2003
6576625 Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections Jun. 10, 2003
6565882 Antibiotic composition with inhibitor May. 20, 2003
6544991 Compositions and methods for treating bacterial infections Apr. 8, 2003
6518252 Method of treating aquatic animals with an antimicrobial agent and chelating agent Feb. 11, 2003
6512004 Promoters of neural regeneration Jan. 28, 2003
6495539 B-lactam-like chaperone inhibitors Dec. 17, 2002
6489317 Method for eradication of Helicobacter pylori Dec. 3, 2002

1 2 3 4 5 6










 
 
  Recently Added Patents
Broadband optical network apparatus and method
(4942
Electronic device with a screen
Reactor core of liquid metal cooled reactor
Pyrrolidine derivatives, pharmaceutical compositions containing the same, and methods of using the same
Credit flow control scheme in a router with flexible link widths utilizing minimal storage
Haworthia plant named `CAPETOWN`
  Randomly Featured Patents
Apparatus for reducing entrapment of foreign matter along a moveable shaft of a substrate support
Process for the production of biaxially stretched films and apparatus for implementation of the process
N-Benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme
Knob for furniture
Fiber optic replicant lamp
Catalytic process for control of NO.sub.x emissions using hydrogen
Polyphenylene sulfide alloy coated wire
Response time measurement apparatus and method
Time base correction for VTR with variable tape speed
System and method for improving crosstalk errors via the insertion of delay gates